The regulatory file for lumbrokinase
The regulatory file for lumbrokinase has to do more than carry an assay: it has to name the earthworm source, show the route the buyer intends to use, and line up the label with that route. This page sets out the documents and checks the buyer's regulatory team will ask for. It does not decide the route for a given market.
The specification describes the preparation; the regulatory file has to show the source, the route and the label for the destination.
Four facts that anchor the file
The file hangs on four facts: which specification revision is being bought, which lot is being released, which destination and finished product are intended, and what has changed since the last approval. The certificate belongs to the lot, the technical data sheet to the specification, and the safety data sheet to handling. The destination question is answered by the buyer's regulatory team, because it depends on the route and on the finished product, not on the powder alone.
Source is the first difference between lumbrokinase and a mineral or a fermentation ingredient. The preparation comes from earthworm tissue, so the file should name the species, the tissue, the country of origin and the feed or culture record. A line that says only “animal-derived” does not identify a source. Allergen, GMO and residual-solvent statements belong beside it, along with any declaration the customer requires.
Version control is part of the file. A dated list that ties the quotation, the specification and the certificate to the same revision is more useful than a folder of unnumbered PDFs. When a statement is missing for a lot, record the gap and close it before dispatch rather than after the shipment reaches the port.
European Union
In the EU, the review runs through several instruments at once. Food supplements sit under Directive 2002/46/EC, general food law under Regulation (EC) No 178/2002, labelling under Regulation (EU) No 1169/2011 and contaminants under Commission Regulation (EU) 2023/915. Health claims are a separate regime under Regulation (EC) No 1924/2006. The current consolidated text is the reference, not a summary.
The route question is whether the preparation is a novel food. The test is the history of use as a food in the EU before 15 May 1997, not the word “enzyme” on the label. If that history cannot be shown, Regulation (EU) 2015/2283 applies and the buyer's regulatory team has to establish what evidence the reviewer will accept. This page does not assert that a route exists for any market. Great Britain keeps its own novel-food register and labelling rules, while Northern Ireland follows the EU framework, so the destination has to be checked market by market.
United States
In the US, the route depends on whether the material is sold as a dietary ingredient or as a food. A dietary ingredient marketed before 15 October 1994 sits under DSHEA; one that was not may need a new dietary ingredient notification under 21 CFR 190.6. A food use follows a different path, and a GRAS conclusion is a separate file with its own evidence. The buyer's regulatory team confirms which path applies and whether the evidence covers the finished product.
The label is reviewed apart from the certificate. The Supplement Facts panel has to name the ingredient and the amount, and the claim review asks whether the wording is allowed for that ingredient in that product. A certificate is not a claim approval, and a claim review does not alter the specification.
Contaminants and limits
The contaminant calculation is done on the finished product, at the dose that will be consumed, not only on the drum. The table gives starting references for a supplement file; the destination's current text and the daily intake decide the operative limit.
| Parameter | Starting reference | Evidence the file needs |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the supplement | Measured result, method, limit and the intake calculation |
| Cadmium (Cd) | 1.0 mg/kg in the supplement | Measured result and any exception for the category |
| Mercury (Hg) | 0.10 mg/kg in the supplement | Measured result and the method used |
| Arsenic (As) | Customer or market limit | Agreed limit, method and measured value |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g | Lot count and absence statement for E. coli and Salmonella |
The US federal framework does not impose a single heavy-metal ceiling on supplements in the way the EU contaminant regulation does; the agreed specification and the applicable state rules carry more of the weight. That makes the specification the operative document and puts the method and detection limit inside the commercial agreement.
Claims and the label
No disease-related claim is made for this material, and the label review should begin there. The fibrin plate is a laboratory tool: it measures what the preparation does to a substrate in a dish, not what it does in a person. That measurement is not a health claim and must not be written as one. In the US, a structure/function statement has its own review and, where applicable, a notification and disclaimer; in the EU, a health claim needs authorisation and a place on the register.
“Fibrinolytic” describes the assay, not a benefit. The ingredient name and the activity unit are label facts; the claim is a separate review. If the formula contains other enzymes, each activity needs its own declaration and its own basis, because a combined enzyme-blend figure does not show how much of either preparation is present.
Documents to keep with the lot
- Lot certificate with the fibrin-plate method, standard and measured activity.
- Specification at the quoted revision, covering activity, protein, moisture, metals and microbiology.
- Safety data sheet with the respiratory-sensitiser and dust statements.
- Source record: earthworm species, tissue, origin, feed or culture, and the supplier declaration.
- Allergen, GMO and residual-solvent statements, plus the animal-origin questionnaire.
- Stability summary for the pack being bought and the assigned retest period.
- Change-control procedure for source, process, carrier and pack.
Checklist before the first order
- The specification revision, CAS 556743-18-1 and the source species are named.
- The activity method, standard and basis are written down, not only the U/g result.
- Certificate, technical data sheet, safety data sheet and source statements are on file.
- The contaminant results have been recalculated for the finished-product dose.
- Label and claim wording has been reviewed for the destination market.
- Source, process, carrier and pack are covered by change control.
For the catalogue values, see the lumbrokinase hub. The COA page explains how the lot certificate is structured; the identity page sets out the supporting tests. The quality page describes the release file, and the EU regulatory note gives the framework references.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation